Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    9472883 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated E-Selectin Nasal Spray to Prevent Stroke Recurrence
Conditions: Cerebrovascular Accident;   Transient Ischemic Attack
Intervention: Drug: E-Selectin nasal spray

Study has passed its completion date and status has not been verified in more than two years.